The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Evidence in Practice

Friday, 19 May 2017
Treatment for erectile dysfunction (ED) with phosphodiesterase-5 (PDE5) inhibitors is associated with a markedly reduced risk of death, and hospitalisation for heart failure. A team from the Karolinksa Institute in Stockholm conducted a nationwide cohort study which included over 43,000 men with a first MI in Sweden.
Friday, 19 May 2017
New research from a large national database shows an increased risk of adverse outcomes in babies born to mothers with gestational diabetes when compared with non-diabetic mothers. The database of all 797,346 deliveries in France in 2012 included 57,629 (7.24%) mothers with gestational diabetes. There was an increased risk of a number of complications for mothers with gestational diabetes compared with non-diabetic mothers.
Topics covered:
Friday, 19 May 2017
The direct factor Xa inhibitor rivaroxaban has been showing promise in trials in venous thromboembolism (VTE) and peripheral arterial disease (PAD). We provide details from the EINSTEIN CHOICE and COMPASS trials.
Tuesday, 11 April 2017
Painkillers considered harmless by the general public are associated with increased risk of cardiac arrest, according to recent research.
Tuesday, 11 April 2017
Type 2 diabetes can be reversed with intensive medical treatment using medications and lifestyle therapies, according to a new study. Up to 40% of study participants were able to stay in remission three months after stopping diabetes medications.
Topics covered:
Tuesday, 11 April 2017
Detailed results from the FOURIER cardiovascular outcomes trial on evolocumab were presented at a late-breaking oral presentation at the American College of Cardiology meeting in Washington DC recently. This is the first major outcomes study to be published for a PCSK9 inhibitor – a new class of cholesterol-lowering medicines.
Topics covered:
Sunday, 12 March 2017
A new study questions the feasibility and value of primary care screening for peripheral arterial disease (PAD). The PIPETTE study is the first UK study of PAD prevalence for nearly a decade.
Sunday, 12 March 2017
Atrial fibrillation patients with insulin-requiring diabetes are at greater risk of suffering a stroke or systemic embolism than those with non-insulin requiring diabetes, or no diabetes at all. While diabetes is a known risk factor for thromboembolic events, this finding sheds new light on the role of insulin in the clinical setting.
Topics covered:

Article search and filter